Guardion Health Sciences Inc (GHSI) Quote

Time for the flush

No $ volume

That’s why u should be at Emge

Short

Trade zero pos slippage my shares dissapeared lol

Are you still bullish?

If like to see that too! But I think we close higher and break 0.2

I'm thinking that GHSI goes over .17 today but will probably close out the day somewhere around the .165 level.

It appears so

GHSI $GHSI I wish it to be . Chart looks great

You just might be correct I think GHSI has a lot of potential.

Ok maybe I

Grabbed 25K shares not selling till at least I see what happens. But def not under 0.26 my first target.

Super bullish. This is going to go parabolic.

GHSI...

GSHI +31% @ $0.1808




Stockholders' Equity per share is 46¢ (28.1M / 61.6M OS)

Unbelievable volume. PPS up but looks like a lot of shares are now available. Made some $$. Holding a little.

GHSI

Premarket volume. PPS up. News.

GHSI

I’m thinking back to 1

I'm thinking that GHSI makes a move for .19 today. It might even move past the .20 level. Any thoughts?

Ya ....revserse split or be delisted...not a warm and fuzzy feeling...but who knows...

Well they have a plan and that came out today , they want to uplist

SQUEEZE COMING $$$$

Actually I sold into strength at .1875 (didn't get the high of the day, but happy) ...purchased at .165 & .159 late last week ..made a nice little profit (which was my goal).
If it falls under .17 again...probably tomorrow...I'll buy again.
This could be a decent long term play...but right now (in today's market environment) I'm playing short term for a while.
Good luck to all!

Tic toc tic toc $$$$

You sold to early lol

Sold at .1875...trying to reload at ~ .169
Playing the gap filling strategy (doesn't always happen ...but may times it does)!

Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories

Source: GlobeNewswire Inc.

Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with OmegaQuant Laboratories (“OmegaQuant”) to provide Guardion with analytic testing and laboratory support services for current and future products. Guardion is a clinical nutrition company that offers a portfolio of science-based, clinically-developed products that are designed to support the health needs of consumers, healthcare professionals and providers and their patients.
OmegaQuant is an independent, CLIA-certified laboratory located in Sioux Falls, South Dakota that offers an extensive suite of clinical tests to researchers, clinicians and the public, including Omega-3 Index, Vitamin D, Prenatal DHA and Mother’s Milk DHA testing. OmegaQuant performs fatty acid analysis for commercial and academic research collaborators and for consumers interested in monitoring their nutritional status in both blood and breast milk. The Omega-3 Index tests measure all the fatty acids in the blood, and reports levels of all 24 fatty acids, as well as the Omega-3 index, Ratios, and the Trans Fat Index.

“This relationship with OmegaQuant positions us to conduct a variety of research projects around both our current product lines, as well as to evaluate future products for efficacy,” commented Bret Scholtes, Guardion’s Chief Executive Officer. “While we are still in the early stages of the relationship, we anticipate applying the Omega-3 Index test to advance the science of our current products, including the recently launched Omega Boost 1,200 mg Omega-3 Gel Bites recently launched under the Guardion flagship Viactiv® brand.”

“We look forward to launching research projects with Guardion as we have with several top institutions such as Harvard University and the NIH, as well as with multiple healthcare businesses,” added Jason Polreis, OmegaQuant’s Chief Executive Officer. “Our proprietary standardized and validated testing helps organizations and individuals through their doctors better understand blood chemistry and the impact that fatty acid composition may have on overall health.”

About Guardion Health Sciences, Inc.

Guardion Health Sciences, Inc. (Nasdaq: GHSI) is a clinical nutrition company. Guardion’s portfolio of science-based, clinically developed products are designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company’s combination of expertise and scientifically supported products is the foundation of Guardion’s growing position within the clinical nutrition marketplace. Information and risk factors with respect to Guardion and its business, including its ability to successfully develop and commercialize its proprietary products and technologies, may be obtained in the Company’s filings with the U. S. Securities and Exchange Commission (the “SEC”) at www.sec.gov.

Forward-Looking Statement Disclaimer

With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by or that otherwise include the words “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may” and “could” are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements involve unknown risks and uncertainties that may individually or materially impact the matters discussed herein for a variety of reasons that are outside the control of the Company, including, but are not limited to, the Company’s ability to raise sufficient financing to implement its business plan, the integration of a new management team, the integration of one or more acquisitions and targets, the impact of the COVID-19 pandemic on the Company’s business, operations and the economy in general, the Company’s ability to successfully develop and commercialize its proprietary products and technologies, and the Company’s ability to maintain compliance with Nasdaq’s listing requirements. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:
CORE IR
Scott Arnold
516-222-2560
scotta@coreir.com

Media Relations Contact:
Jules Abraham
Director of Public Relations
CORE IR
917-885-7378
julesa@coreir.com

Good call. Past 18 premarket.

GHSI

Good call. Past 18 premarket.

GHSI

I lucked out the same way.

GHSI

Lucky bid filled @ .1572. I had a couple orders a little higher.

GHSI

I'm thinking that the few you got this morning just might blow past the .18 level very early in tomorrow's trading session.

GHSI

Got a few.

GHSI

Premarket bid. Will this dip a bit more?


GHSI

Premarket bid. Will this dip a bit more?


GHSI

Squeeze on:))

Jumped in today @ .165 & .1597

Make that 125k average .1602

Took a starter 75k @.1615, will soon see how bright that was..

Let’s goooo$$$$

27 cents Friday?! Strong EOD momentum!!!

109,000 dollar bid just flashed

It bounces higher, cools bounces higher, cools, higher and higher!!! 55 cents is coming very quickly!!!

Gotta break .25/.27

You can see it's gonna SCREAM!!!

Probably more PR's coming to propel GHSI higher.

Right back to 55 cents! Onward...

It’ll fly away at .27

Nice move incoming weee$$$